Belgium

CureVac Announces Decision of German Federal Patent Court in Wide-Ranging Patent Litigation with BioNTech SE

The validity of the CureVac EP 1 857 122 B1 patent rejected by the German Federal Patent Court after a revocation action filed through BioNTech SEDecision does not resolve the ongoing litigation in Germany over seven other intellectual asset rights, covering falsified grounds. . .

CureVac Announces Decision of German Federal Patent Court in Wide-Ranging Patent Litigation with BioNTech SE Read More »